Our Mission
We’re redefining breast health through accessible, intuitive, and affordable technology. Our mission is to empower women to build awareness and confidence in their bodies-independently, privately, and from home.
Our Mission
We’re redefining breast health through accessible, intuitive, and affordable technology. Our mission is to empower women to build awareness and confidence in their bodies-independently, privately, and from home.
Clinical trials with Solis Mammography and Radnet imaging in the works, follow us for results
Feminai's patented technology combines advanced wearable sensors with AI-powered analysis to detect physiological changes associated with breast tissue density and blood flow.
In first-in-human clinical trials conducted at Sheba Medical Center our technology demonstrated
96% sensitivity and a 98% negative predictive value (NPV).
.png)
Clinical Validation
Feminai Validation Study
Conducted at Sheba Medical Center, our clinical validation study demonstrated high sensitivity and specificity across a diverse population of women with both normal and abnormal mammography findings.
These results support the potential of Feminai's wearable AI platform as an accessible and reliable breast health assessment solution.
